Autoimmune Type 1 Diabetes

People who develop autoimmune Type 1 Diabetes (T1D) face a lifelong, multi-facetted burden that is both physical and psychological. If the person who is diagnosed is a child or adolescent, this burden often affects the child’s entire family, as well as the child’s social relations such as daycare, school, and friends.

Curious about the characteristics of pre-symptomatic- and stage 3 Type 1 Diabetes? Interested in learning about the potential benefits of screening for autoimmune Type 1 Diabetes?

This infographic summarizes survey data^* about the impact that families across the Nordic countries have felt when being diagnosed with autoimmune Type 1 Diabetes (T1D).

Systematic early detection of autoimmune Type 1 Diabetes might be a new way to avoid acute and chronic complications of the condition. This new approach may play a role as a revolutionary shift, helping to shape the future of Type 1 Diabetes management.

Start to think differently about Type 1 Diabetes by considering the pre-symptomatic stages of the condition and how it affects people of all ages and their families.

In 10 minutes or an hour, get a view of the discussion from the webinar “Early Detection and Surveillance of Autoimmune Type 1 Diabetes”.

Anti-islet autoantibodies that target proteins associated with beta-cells serve as biomarkers of autoimmune type 1 diabetes (T1D) development. The number of detectable autoantibodies through screening correlates with risk of developing autoimmune T1D. Assays for detecting autoimmune T1D have shown high sensitivity and specificity.